Table 2 Hoehn and Yahr staging of Parkinson’s disease at baseline and following subcutaneous infusion of apomorphine.

From: Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience

HY stage*

Baseline

n (%)

Month 6

n (%)

pa

Month 12

n (%)

pb

2.0

–

–

< 0.001

19 (37.3)

0.013

2.5

2 (3.9)

3 (5.9)

32 (62.7)

3.0

34 (66.7)

25 (49.0)

–

3.5

13 (25.5)

21 (41.2)

–

4

2 (3.9)

2 (3.9)

–

  1. aChi-square test for baseline vs month 6 scores; bChi-square test for baseline vs month 12 scores; *Hoehn and Yahr stage of Parkinson’s disease. p < 0.05 was considered significant.
Back to article page